Skip to Main Content

Author Details

Rita A Sakr
Universite Libre de Bruxelles
2000
49
24
PMIDPaper TitleJournal TitlePublished Year
34487986Unusual metastasis in BRCA mutated pancreatic cancer while on maintenance Olaparib: Two case reports and review of the literature.Eur J Cancer2021
30185420Lobular Carcinomas <i>In Situ</i> Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma.Clin Cancer Res2019
28921573Contralateral breast cancers: Independent cancers or metastases?Int J Cancer2018
28612228Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.Breast Cancer Res Treat2017
28299801Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer.J Pathol2017
29067601Do Lumpectomy Cavity Shaved Margins Really Not Impact Re-excision Rates in Breast Cancer?Ann Surg Oncol2017
26726007Biomarkers That Predict Sensitivity to Heat Shock Protein 90 Inhibitors.Clin Breast Cancer2016
26643573Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.Mol Oncol2016
26497122Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile.Histopathology2016
27334989Clonal relationships between lobular carcinoma in situ and other breast malignancies.Breast Cancer Res2016
26806567Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations.J Pathol2016
26960396The Genomic Landscape of Male Breast Cancers.Clin Cancer Res2016
25601220Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion.Mol Oncol2015
26301495In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer.Nat Genet2015
26371145Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.J Clin Oncol2015
25953157Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer.Ann Oncol2015
24634376PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinoma.Clin Cancer Res2014
25240283Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands.Nat Genet2014
23286959[Does molecular biology play any role in ductal carcinoma in situ?].Gynecol Obstet Fertil2013
24141896Is there a role for routine screening MRI in women with LCIS?Breast Cancer Res Treat2013
24185512ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.Nat Genet2013
23890733Progression from ductal carcinoma in situ to invasive breast cancer: revisited.Mol Oncol2013
21935747Is there a low-grade precursor pathway in breast cancer?Ann Surg Oncol2012
23092874Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer.Clin Cancer Res2012
22787290Can the centrosome be a marker for DNA ploidy in breast cancer?J Cytol2012
22843922Impact of immunohistochemical analysis of sentinel lymph node biopsy on breast cancer management.Anticancer Res2012
22080244Cadherin-catenin complex dissociation in lobular neoplasia of the breast.Breast Cancer Res Treat2012
22144499Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).Cancer Epidemiol Biomarkers Prev2012
21777924Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozole.J Surg Res2012
21277728Clear margins for invasive lobular carcinoma: a surgical challenge.Eur J Surg Oncol2011
22053997Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.Breast Cancer Res2011
21372684Occult malignancy in patients undergoing contralateral prophylactic mastectomy.Ann Surg2011
21464413Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.J Clin Oncol2011
21464011[Are centrosomal abnormalities correlated to DNA ploidy in breast cancer?].Ann Biol Clin (Paris)2011
20216404Protocol for PTEN expression by immunohistochemistry in formalin-fixed paraffin-embedded human breast carcinoma.Appl Immunohistochem Mol Morphol2010
18755562Pain and complications of directional vacuum-assisted stereotactic biopsy: comparison of the Mammotome and Vacora techniques.Eur J Radiol2009
20101283Silicone migration to the contralateral axillary lymph nodes and breast after highly cohesive silicone gel implant failure: a case report.Cases J2009
19829987Uterine adenosarcoma associated to lymphovascular emboli: a case report.Cases J2009
19364652Accuracy of stereotactic vacuum-assisted breast biopsy with a 10-gauge hand-held system.Breast2009
18186866Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.Breast J2008
19143859The sentinel lymph node procedure for patients with preoperative diagnosis of ductal carcinoma in situ: risk factors for unsuspected invasive disease and for metastatic sentinel lymph nodes.Int J Clin Pract2008
18440190Risk of breast cancer associated with papilloma.Eur J Surg Oncol2008
17937100Unscarred uterine rupture--case report and literature review.Clin Exp Obstet Gynecol2007
16967457Ductal carcinoma in situ: value of sentinel lymph node biopsy.J Surg Oncol2006
15808389Diagnosis and management of adenocarcinoma of the ampulla of Vater during pregnancy.Eur J Obstet Gynecol Reprod Biol2005
12575014Intrauterine brain teratoma: a case report of imaging (US, MRI) with neuropathologic correlations.Prenat Diagn2003
14562644Spontaneous rupture of a first-trimester gravid uterus in a woman exposed to diethylstilbestrol in utero. A case report.J Reprod Med2003
14618673Normal pregnancy following first-trimester uterine rupture.Ultrasound Obstet Gynecol2003
11244637[Effects of hormone replacement therapy for menopause on prognostic factors of breast cancer].Gynecol Obstet Fertil2000
  • 1 - 49 of 49

Recommended Authors

Francisco Beca
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 9
Leonard Da Silva
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
Career Start Year 2007
Number of shared co-authors 10
Jeong Eon Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Carolien H M van Deurzen
Erasmus MC Cancer Institute
Career Start Year 2004
Number of shared co-authors 33
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year 2003
Number of shared co-authors 10
Tanya L Hoskin
Division of Biostatistics and Clinical Trials, Mayo Clinic
Career Start Year 2003
Number of shared co-authors 4
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 1
Judy C Boughey
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 4
Willem Vreuls
Canisius Wilhelmina Hospital
Career Start Year 2000
Number of shared co-authors 1
Isabel T Rubio
Clinica Universidad de Navarra, Cancer Center Universidad de Navarra
Career Start Year 1998
Number of shared co-authors 4
Lavinia P Middleton
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 3
Amy C Degnim
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 3
Sarah L Blair
University of California
Career Start Year 1996
Number of shared co-authors 1
Susan J Done
University Health Network
Career Start Year 1994
Number of shared co-authors 4
Peter Bult
Radboud University Medical Center
Career Start Year 1994
Number of shared co-authors 5
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 26
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 1
Wey L Leong
University Health Network
Career Start Year 1992
Number of shared co-authors 3
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 4
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 9
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 14
Christos Markopoulos
National and Kapodistrian University of Athens
Career Start Year 1987
Number of shared co-authors 3
Elizabeth Mallon
Queen Elizabeth University Hospital
Career Start Year 1986
Number of shared co-authors 2
Craig D Shriver
Walter Reed National Military Medical Center
Career Start Year 1985
Number of shared co-authors 0
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 0
Bruce Youngson
University Health Network
Career Start Year 1985
Number of shared co-authors 3
David R McCready
University of Toronto, University Health Network
Career Start Year 1984
Number of shared co-authors 6
Jos?? Palacios
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 17
Sunil R Lakhani
University of Queensland
Career Start Year 1983
Number of shared co-authors 26
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 16

Collaborators

Tari A King
Co-authored papers 22
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 14
Charlotte K Y Ng
University of Bern
Co-authored papers 12
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers 12
Salvatore Piscuoglio
University of Basel
Co-authored papers 9
Martine Antoine
Erasme University Hospital, Universite Libre de Bruxelles
Co-authored papers 6
Larry Norton
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 5
Clifford A Hudis
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Co-authored papers 4
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Luciano G Martelotto
Monash University
Co-authored papers 3
Agnes Viale
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Nicola Fusco
IEO European Institute of Oncology IRCCS
Co-authored papers 3
Noralane M Lindor
Mayo Clinic
Co-authored papers 2
Fergus J Couch
Mayo Clinic
Co-authored papers 2
Claudine Isaacs
Co-authored papers 2
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 2
Sue Healey
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Timothy R Rebbeck
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 2
Mark E Sherman
Mayo Clinic
Co-authored papers 2
Esther M John
Co-authored papers 2
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
David E Goldgar
University of Utah
Co-authored papers 2
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 2
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers 2
James Hicks
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 2
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Ana Osorio
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 2
Susan M Domchek
Co-authored papers 2
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 2
Release 1.2